瘤区淋巴结的新治疗策略:阳性清除之,阴性保留之,可疑观察之
摘要
目前,肿瘤TNM分期中的淋巴结(N)分期是恶性实体瘤最常采用的临床分期系统之一。一般认为淋巴结状态是大多数恶性实体瘤患者生存预后最重要的因素之一。近年来,外科学者们对肿瘤患者提出了各种各样的淋巴结清扫术式。
出处
《中华医学杂志》
CAS
CSCD
北大核心
2012年第21期1443-1447,共5页
National Medical Journal of China
参考文献20
-
1修方明,曹雪涛.肿瘤引流淋巴结的免疫学性质及其抗肿瘤作用的研究进展[J].国外医学(免疫学分册),1995,18(4):170-174. 被引量:5
-
2Yoneyama H, Matsuno K, Matsushimaa K. Migration of dendritic cells. Int J Hematol,2005, 81: 204-207.
-
3Flores-Romo L. In vivo maturation and migration of dendritic cells. Immunology,2001,102:255-262.
-
4Edge SB, Compton CC. The American Joint Committee on Cancer:the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol,2010,17:1471-1474.
-
5Moynihan BGA. The surgical treatment of cancer of the sigmoid flexure and rectum. Surg Gynecol Obster,1908, 6: 463-466.
-
6ASCO meeting. Number of lymph nodes removed determines colon cancer survival: a second analysis of INT-0089. Oncology, 2000, 9 : 725-730.
-
7Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol,2002,26 : 179-189.
-
8邢伟,陈杰,田建明.淋巴结病变影像学诊断进展[J].国际医学放射学杂志,2009,32(2):112-115. 被引量:6
-
9Mvarez S, Anorbe E, Alcorta P, et al. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol,2006,186 : 1342-1348.
-
10Rubaltelli L, Khadivi Y, Tregnaghi A, et al. Evaluation of lymph node perfusion using continuous mode harmonic ultrasonography with a second-generation contrast agent. J Ultrasound Med, 2004, 23:829-836.
二级参考文献17
-
1Lyshehik A Higashi T Asato R 王延安.声弹性成像诊断淋巴结转移癌的初步经验[J].中国口腔颌面外科杂志,2007,5(3):224-224. 被引量:55
-
2Hany TF,Steinert HC,Goerres GW,et al.PET diagnostic accuracy:improvement with in-line PET-CT system:initial results.Radiology,2002,225:575-581.
-
3Takamochi K,Yoshida J,Murakami K,et al.Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.Lung Cancer,2005,47:235-242.
-
4Freudenberg LS,Antoch G,Schutt P,et al.FDG-PET/CT in restaging of patients with lymphoma.Eur J Nucl Med Mol Imaging,2004,31:325-329.
-
5Curtin HD,Ishwaran H,Mancuso AA,et al.Comparison of CT and MRIimaging in staging of neck metastases.Radiology,1998,207:123-130.
-
6Antoch G,Vogt FM,Freudenberg LS,et al.Whole-body dualmodality PET/CT and whole-body MRIfor tumor staging in oncology.JAMA,2003,290:3199-3206.
-
7van den Brekel MW,Stel HV,Castelijns JA,et al.Cervical lymph node metastasis:assessment of radiologic criteria.Radiology,1990,177:379-384.
-
8King AD,Ahuja AT,Leung SF,et al.Neck node metastases from nasopharyngeal carcinoma:MRIimaging of patterns of disease.Head Neck,2000,22:275-281.
-
9Yen TC,Chang YC,Chan SC,et al.Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumor and loco-region nodes? Eur J Nucl Med Mol Imaging,2005,32:541-548.
-
10Chong VF,Mukherji SK,Ginsberg LE,et al.Nasopharyngeal carcinoma:review of how imaging affects staging.J Comput Assist Tomogr,1999,23:984-993.
共引文献31
-
1宋金玉,陈渝晖,杨亚英.淋巴结病变CT灌注成像研究进展[J].昆明医科大学学报,2009,32(S2):62-66. 被引量:1
-
2单保恩,李启亮,张超,何明,张正茂.不同刺激诱导肺癌患者引流淋巴结细胞抗自体肿瘤的体外研究[J].中国免疫学杂志,2006,22(5):431-434. 被引量:2
-
3何明,单保恩.肿瘤引流淋巴结与肿瘤免疫[J].国际呼吸杂志,2006,26(9):660-662.
-
4熊正平,张阳德,谢爱民,梁赵玉,何庆.鼻咽癌TNM分期的PET/CT表现与血清VEGF表达的关系[J].临床放射学杂志,2008,27(1):28-32. 被引量:3
-
5黄江琼,王安宇,朱小东,苏丹柯,张俊,秦朝军,黄盛才,陈军.PET-CT和MRI诊断兔鼻咽肿瘤颈淋巴结转移的比较研究[J].中华放射肿瘤学杂志,2009,18(1):43-46. 被引量:1
-
6冯海燕,黄元姣,莫颖禧,周晓莹,黄光武.血浆EBV DNA水平与EBVCA-IGA抗体滴度对鼻咽癌诊断作用的对比研究[J].中国现代医学杂志,2009,19(6):877-879. 被引量:1
-
7贺祖武,翦新春,蒋灿华,陈新群,李旭东.口咽鳞癌颈淋巴结临床触诊、B超和MRI检查的对比分析[J].中国口腔颌面外科杂志,2010,8(2):134-138. 被引量:3
-
8孙新儒,梁培炎,胡莹莹,张旭,林晓平,樊卫.鼻咽癌^(18)F-FDG PET/CT表现和血清EBV-VCA/IgA相关性的研究[J].分子诊断与治疗杂志,2010,2(3):176-180.
-
9赵明,王健鹏,吴沛宏,黄子林,李旺,李传行,姜勇,潘长穿,李雨红,李力人,潘志忠,万德森,徐瑞华.射频消融治疗结直肠癌肝转移及其预后因素分析[J].中华医学杂志,2010,90(23):1587-1592. 被引量:28
-
10黄江琼,王安宇,朱小东,苏丹柯,张俊,秦朝军,黄盛才,陈军.PET-CT诊断免鼻咽VX2移植癌颈部转移淋巴结的价值[J].中国肿瘤临床,2010,37(13):745-748.
-
1过邦辅,凌励立.软组织肿瘤分期系统的近代概念及其评估[J].肿瘤,1999,19(6):319-322. 被引量:2
-
2赵达,田泉,马守成,肖文,侯小明,窦玉安.康莱特注射液联合化疗治疗晚期恶性实体瘤的临床研究[J].现代肿瘤医学,2003,11(4):308-309.
-
3田春桃.恶性实体瘤医院感染70例特征分析[J].河南肿瘤学杂志,1998,11(6):478-480.
-
4柴琴.泰素帝治疗晚期恶性实体瘤疗效观察[J].临床肺科杂志,2006,11(2):170-171. 被引量:2
-
5刘春风,李忠林,解娟.神经母细胞瘤在日本的筛查[J].现代肿瘤医学,2004,12(3):235-237. 被引量:1
-
6罗克桓,石远凯,孙燕.大剂量化疗合并自体骨髓移植治疗成人恶性实体瘤[J].实用肿瘤杂志,1994,9(1):51-53. 被引量:1
-
7魏岩,吴强.Twist-2在宫颈癌中的表达及意义[J].安徽医药,2014,18(10):1913-1915. 被引量:2
-
8王奇璐,冯奉仪.以不同常规剂量顺铂为主的联合化疗对晚期恶性实体瘤的疗效[J].中华肿瘤杂志,1989,11(3):222-225. 被引量:8
-
9宋桂云,曹立盛,关宏伟,董明武,肖在鹏.小儿常见恶性实体瘤多药耐药基因的表达及临床意义[J].中国实用儿科杂志,2003,18(5):284-284.
-
10应晓杨,张永利.老年人恶性淋巴瘤82例临床分析[J].中国老年学杂志,2004,24(6):568-569. 被引量:1